The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica

KVISTGARD, Denmark, May 9 /PRNewswire-FirstCall/ -- Oxford Biomedica's second attempt to dismiss Bavarian Nordic's patent infringement suit in the United States has failed. Instead of denying infringement, Oxford Biomedica made yet another attempt to dismiss the suit arguing that it was premat...

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis

LEUVEN, Belgium and LUND, Sweden, February 23 /PRNewswire-FirstCall/ -- - Trial to Assess the Benefits of Partial Factor VIII Inhibition in Patients Undergoing Knee Replacement Surgery ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (O...

Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients

PRINCETON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that they and their development partner, Roche, have agreed with the FDA on the final design for a phase 2b trial with R7128, a nucleoside inhibitor of hepatitis C (HCV), slated to initiate in the...

MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor

GAITHERSBURG, Md., Dec. 4 /PRNewswire/ -- MedImmune today announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that targets the interleukin-5 receptor (IL-5R). Preclinical da...

Histogen Announces Start of Hair Regrowth Clinical Evaluation

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the start of the Company's first human clinical evaluation of ReGenica for hair regrowth. ReGenica is the first naturally stabilized and bioactive formulation of wnt ...

Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility

MELVILLE, N.Y., Nov. 11 /PRNewswire/ -- Nikon Instruments Inc. has provided an in-kind donation of microscopy equipment to help Clemson University's College of Agriculture, Forestry and Life Sciences biological sciences department start a new core microscopy facility. The facility will be the ...

Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)

CALGARY, June 10 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that patient enrolment has started in a Phase 1/2 clinical trial for patients with metastatic ovarian, peritoneal and fallopian tube cancers using concurrent intravenous (IV)...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March 31, 2008. Q1 2008 Financial Highlights - Product sales up 37% to $632m - New produ...

BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance

Potsdam, Germany, April 15, 2008 / b3c newswire / - In order to enhance the worldwide launch of its innovative food safety testing systems, BIOTECON Diagnostics has formed a strategic marketing alliance with the globally operating MERCK KGaA , Darmstadt, Germany. Merck KGaA sells the food pro...

Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

PROENCY will provide real-world clinical data on the PROMUS(TM) Stent NATICK, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the first patient has been enrolled in its PROENCY (PROMUS(TM), ENdeavor(R) and CYpher(R)) European registry....

Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes

Emmy Nominated Actress Shares Her Personal Story and Tips for Better Blood Sugar Management BRIDGEWATER, N.J., Nov. 1 /PRNewswire-FirstCall/ -- As one of the more than 20 million Americans living with diabetes, Emmy nominated actress and Broadway star Aida Turturro is...

Optherion, Inc. Completes $37 Million Start Up Financing

Financing Will Advance Development of Diagnostics and Disease-Modifying Therapeutics for Dry and Wet Age-Related Macular Degeneration and Other Diseases Associated with Alternative Complement System NEW HAVEN, Conn., Oct. 9 /PRNewswire/ -- Optherion, Inc., a company developing produc...

Health Care Costs Continue Double-Digit Pace, But May Start Moderating in 2004

U.S. health care cost increases continued to escalate at a double-digit pace in 2003, but there are indications that rate hikes may begin moderating as early as next year, according to global HR outsourcing and consulting firm Hewitt Associates (NYSE: HEW). For 2004, Hewitt is projecting a 12.6 per...

Renaissance Learning CEO resigns to start company

Wisconsin Rapids, Wis. Renaissance Learning, which makes computerized assessment and progress monitoring tools for pre-K-12 schools, said late on Wednesday that president and CEO John Hickey, 50, has resigned. He had been president since 1996 and CEO since 2003. "There is never a right time ...

Milwaukee Wi-Fi provider ready to start building network

Milwaukee, Wis. Installation work on Milwaukee's Wi-Fi network could begin in a matter of weeks, representatives of the City of Milwaukee and Midwest Fiber Networks said Thursday. The company is working out final contractual details with the city, which last month selected Midwest Fiber to ...

Will BidRx start a drug price war?

O shkosh, Wis. - BidRx , a new online company that helps consumers shop for more affordable prescription medications, is attempting to create a new healthcare paradigm. The Oshkosh-based business has gone live with its new web site, where consumers can self-register and gain free access to c...

Wisconsin start up Primorigen Biosciences corrals out-of-state investment

Madison, Wis. - Wisconsin-based high-tech startup and spin-off companies are gaining attention from some relatively far-flung investors. The most recent example of this is Primorigen Biosciences LLC , a company that is developing laboratory tools for analysis of cellular reprogramming and differ...

Summer venture investments total $18 million for Wisconsin start ups

Madison, Wis. - This summer, venture investors deployed more than $18 million to tech-based start ups across Wisconsin, a total that may bode well for improving on the state's 2005 venture performance. While it is difficult to draw firm conclusions from one quarter of investment activity, the ...

Eau Claire business contest honors tech start ups

Eau Claire, Wis. - Two companies, including an online application provider, have won the 2006 "Creating Your Own Business" contest sponsored by the Eau Claire Area Economic Development Corp . Winners in the micro business and emerging-growth categories, respectively, were STAGE5, LLC, an onli...

Wausau start up secures $560K for GPS maps

Wausau, Wis. - U.S. Trailmaps, Inc. , a software developer for off-road mapping applications, closed its second round of equity financing this week in a deal with Kegonsa Capital Partners that values the start-up company at $1 million. Trailmaps will receive $560,000 in funds that will enab...

CellCura could start an invasion of stem cell firms

Madison, Wis. - The first segment of a national and international pipeline to Wisconsin might have been put in place with the announcement that CellCura, Inc. , a Norwegian biotechnology and stem cell research company, will be opening a location in Madison's University Research Park . CellCu...

Identity theft start up has fast-track growth plans

Ahmed Fazil Madison, Wis. - The 2006 winner of the Steven Burrill Technology Business Plan Competition has launched its first identity theft product, and has an aggressive plan that calls for profitability in three months and three million customers after two years. This probably sounds l...

Improve Amplification Specificity with Hot Start PCR Enzyme

SureStart Taq DNA polymerase utilizes ultra-pure Taq2000 DNA polymerase SureStart Taq DNA polymerase features a modified version of Taq2000 DNA polymerase with hot start capability. Using SureStart Taq, hot start is in- corporated into PCR protocols previ...

Greater Amplification Specificity with New Hot Start PCR Enzyme

SureStart Taq DNA polymerase makes hot start simple and efficient Jonathan Eads Frances Bai Ronda Allen Holly Hogrefe ...

Pfu DNA Polymerase as a Hot Start Alternative

Traditional hot start additives unnecessary Kirk B. Nielson Janice Cline Holly Hogrefe Stratagene Cloning Systems, Inc. This article describes the important, novel application of Stratagenes Pfu DNA polymerase for minimizing PCR cold start mismatched primer-extension ...

Wisconsins untapped defense might: why saving military bases is just a start

MADISON Gov. Jim Doyles effort to keep Wisconsins five military installations off the Pentagons closure list deserves a crisp salute and not just because those bases bring nearly $850 million per year to the Wisconsin economy. Wisconsin is a hidden fortress of ideas and materials to be used in...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...the use of the Company's unique biomaterials technology for treating articular cartilage defects of the knee. The clinical trial, which is expected to start later this year, will utilize the Company's Cartilage Repair Device, which consists of a proprietary bi-phasic, bioresorbable implant designed to trea...

InterMune to Present at Canaccord Adams Conference

... investor relations page of InterMune's corporate website at www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software. About InterMune InterMune is a biotechnology company focused ...

Synthetech Reports First Quarter Fiscal 2010 Results

... ===== ===== Commenting on the financial results, Dr. Gregory Hahn, President and CEO, stated, "It is a great start for fiscal year 2010. First quarter revenues of $4.7 million, operating profit of 22% and net income of $969,000 further exemplify the benefits of ou...

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

... the call will be Stephanie R. Irish, Acting CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos. The teleconference dial-in numbers are as follows:...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...dy of ITMN-191 in combination with standard of care in August; our plans to start a Phase 1b MAD study of ITMN-191 in combination with low dose ritonavir in ...the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be ...

deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results

...age of deCODE's website, http://www.decode.com , or through http://www.earnings.com . Please log in to the webcast 15 minutes prior to the scheduled start of the call. The call will be archived for at least a week on each site. For those unable to listen to the webcast because of company firewall or othe...

New clues about a hydrogen fuel catalyst

... added that the research benefitted from being based at PNNL. "An important part about this work is that we have these kinds of DOE teams where we can start with experiments and go to theory and back again. We get a lot more information this way than doing either one alone." ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...apy (ERT) or who have not received ERT for at least six months prior to the start of treatment with Amigal. The Amigal treatment arm dose and regimen will b...b participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After...

Pharmasset to Present at Canaccord Adams Conference

...or Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm . Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast. A repla...

GeoVax Labs, Inc. Provides Clinical Studies Update

...ls - Planning for Phase 1 To help serve those people who are already infected with HIV, the Company is preparing for a Phase 1 therapeutic trial to start in early 2010. "The goal here is to reduce the need for anti-viral drugs. This initial trial will determine the safety and immunogenicity of the vac...

NxStage Reports Second Quarter 2009 Financial Results

...r relations section of the Company's website at www.nxstage.com/ir.cfm . A replay of the conference call will be available 3 hours after the start of the call through August 19, 2009. To access the replay dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 52867664. ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

...e United States and Canada or +1(706) 679-8297 internationally. The conference ID is 22377396. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 11, and may be accessed by dialing (8...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...17-213-4849, at least 10 minutes prior to the call start time. The participant passcode for this conferenc...all at anytime, including up to and after the call start time, at https://www.theconferencingservice.com... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to download...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

...ucting a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ... in over 30 countries. For more information on the start trial, or to find a participating center and eligi...